Pu-Chun Ke is a Signature Project Leader at CBNS-Monash and a Principal Fellow at the University of Queensland. He was a CSIRO Distinguished Visiting Scientist and tenured Associate Professor at Clemson University, USA. Dr Ke was recipient of a CAREER Award (US National Science Foundation) and LJIS Postdoctoral Fellowship in Biophysics (Burroughs Wellcome Fund through the University of California, San Diego). He has authored 150 papers (15 featured as covers), including 18 reviews, on amyloid diseases and mitigation, protein corona, single molecules, and environmental health and safety of nanomaterials.
|Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer||2016||Gurzov,E. N.; Wang, B.; Pilkington, E. H.; Chen, P.; Kakinen, A.; Stanley, W. J.; Litwak, S. A.; Hanssen, E. G.; Davis, T. P.; Ding F.; Ke, P. C|
|Implications of peptide assemblies in amyloid diseases||2017||Pu Chun Ke, Marc-Antonie Sani, Feng Ding, Aleksandr Kakinen, Ibrahim Javed, Frances Separovic, Thomas P. Davis, Raffaele Mezzenga|
|NanoEHS beyond toxicity – focusing on biocorona||2017||Sijie Lin, Monika Mortimer, Ran Chen, Aleksandr Kakinen, Jim E. Riviere, Thomas P. Davis, Feng Ding and Pu Chun Ke|